A return to ‘pre-pandemic levels’

Shortages of intravenous and subcutaneous Actemra have been resolved as pharmacists thanked for their patience A shortage of Actemra (tocilizumab) has finally been resolved after supply was battered following recommendations last year by the World Health Organisation (WHO) for the drug to be used as a treatment for patients seriously ill COVID-19. In July last